Trial Outcomes & Findings for Social Media and Cancer Screening Information (NCT NCT06712901)
NCT ID: NCT06712901
Last Updated: 2026-03-20
Results Overview
To determine which colorectal cancer screening (CRCS) participants are most likely to choose. Response options: stool-based tests (e.g., FOBT or FIT); endoscopic/scoping approach (e.g., colonoscopy or sigmoidoscopy); whatever my doctor recommends to me; something other than a stool-based or scoping approach; I would not follow the recommendations. This outcome will report the count of responses.
COMPLETED
NA
2030 participants
15 minutes
2026-03-20
Participant Flow
Participant milestones
| Measure |
Control (no Exposure)
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
Median Ranked
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Overall Preferred
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
382
|
404
|
420
|
411
|
413
|
|
Overall Study
COMPLETED
|
382
|
404
|
420
|
411
|
413
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Social Media and Cancer Screening Information
Baseline characteristics by cohort
| Measure |
Overall Preferred
n=420 Participants
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
n=411 Participants
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
n=413 Participants
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
Median Ranked
n=404 Participants
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Control (no Exposure)
n=382 Participants
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
Total
n=2030 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
281 Participants
n=154 Participants
|
284 Participants
n=151 Participants
|
292 Participants
n=305 Participants
|
269 Participants
n=104 Participants
|
263 Participants
n=22 Participants
|
1389 Participants
n=21 Participants
|
|
Age, Categorical
>=65 years
|
139 Participants
n=154 Participants
|
127 Participants
n=151 Participants
|
121 Participants
n=305 Participants
|
135 Participants
n=104 Participants
|
119 Participants
n=22 Participants
|
641 Participants
n=21 Participants
|
|
Age, Continuous
|
59.59 years
STANDARD_DEVIATION 8.34 • n=154 Participants
|
59.59 years
STANDARD_DEVIATION 8.18 • n=151 Participants
|
59.51 years
STANDARD_DEVIATION 7.88 • n=305 Participants
|
60.26 years
STANDARD_DEVIATION 8.22 • n=104 Participants
|
59.77 years
STANDARD_DEVIATION 8.24 • n=22 Participants
|
59.74 years
STANDARD_DEVIATION 8.17 • n=21 Participants
|
|
Sex: Female, Male
Female
|
240 Participants
n=154 Participants
|
217 Participants
n=151 Participants
|
201 Participants
n=305 Participants
|
209 Participants
n=104 Participants
|
193 Participants
n=22 Participants
|
1060 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
180 Participants
n=154 Participants
|
194 Participants
n=151 Participants
|
212 Participants
n=305 Participants
|
195 Participants
n=104 Participants
|
189 Participants
n=22 Participants
|
970 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
420 Participants
n=154 Participants
|
411 Participants
n=151 Participants
|
413 Participants
n=305 Participants
|
404 Participants
n=104 Participants
|
382 Participants
n=22 Participants
|
2030 Participants
n=21 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Black or African American
|
211 Participants
n=154 Participants
|
205 Participants
n=151 Participants
|
211 Participants
n=305 Participants
|
201 Participants
n=104 Participants
|
194 Participants
n=22 Participants
|
1022 Participants
n=21 Participants
|
|
Race (NIH/OMB)
White
|
209 Participants
n=154 Participants
|
206 Participants
n=151 Participants
|
202 Participants
n=305 Participants
|
203 Participants
n=104 Participants
|
188 Participants
n=22 Participants
|
1008 Participants
n=21 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
00 Participants
n=305 Participants
|
0 Participants
n=104 Participants
|
0 Participants
n=22 Participants
|
0 Participants
n=21 Participants
|
|
Region of Enrollment
United States
|
420 participants
n=154 Participants
|
411 participants
n=151 Participants
|
413 participants
n=305 Participants
|
404 participants
n=104 Participants
|
382 participants
n=22 Participants
|
2030 participants
n=21 Participants
|
PRIMARY outcome
Timeframe: 15 minutesPopulation: One participant in the Black American Preferred group left this item blank.
After reading cancer screening (CRCS) recommendations, this outcome will assess how likely they are to follow on the the screening recommendations. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.
Outcome measures
| Measure |
Overall Preferred
n=420 Participants
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
n=410 Participants
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
n=413 Participants
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
Median Ranked
n=404 Participants
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Control (no Exposure)
n=382 Participants
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
|---|---|---|---|---|---|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
2 Unlikely
|
18 Participants
|
11 Participants
|
16 Participants
|
7 Participants
|
16 Participants
|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
1 Very Unlikely
|
18 Participants
|
16 Participants
|
21 Participants
|
19 Participants
|
24 Participants
|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
3 Neutral
|
34 Participants
|
46 Participants
|
44 Participants
|
35 Participants
|
32 Participants
|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
4 Likely
|
125 Participants
|
123 Participants
|
121 Participants
|
125 Participants
|
124 Participants
|
|
Intentions to Adhere to Colorectal Cancer Screening (CRCS) Recommendations
5 Very Likely
|
225 Participants
|
214 Participants
|
211 Participants
|
218 Participants
|
186 Participants
|
PRIMARY outcome
Timeframe: 15 minutesTo determine which colorectal cancer screening (CRCS) participants are most likely to choose. Response options: stool-based tests (e.g., FOBT or FIT); endoscopic/scoping approach (e.g., colonoscopy or sigmoidoscopy); whatever my doctor recommends to me; something other than a stool-based or scoping approach; I would not follow the recommendations. This outcome will report the count of responses.
Outcome measures
| Measure |
Overall Preferred
n=420 Participants
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
n=411 Participants
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
n=413 Participants
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
Median Ranked
n=404 Participants
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Control (no Exposure)
n=382 Participants
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
|---|---|---|---|---|---|
|
Intentions to Adhere Test Preference Indication
Stool-based
|
106 Participants
|
93 Participants
|
118 Participants
|
97 Participants
|
93 Participants
|
|
Intentions to Adhere Test Preference Indication
Endoscopic/Scoping
|
153 Participants
|
117 Participants
|
129 Participants
|
123 Participants
|
123 Participants
|
|
Intentions to Adhere Test Preference Indication
Doctor's recommendation
|
147 Participants
|
181 Participants
|
150 Participants
|
166 Participants
|
146 Participants
|
|
Intentions to Adhere Test Preference Indication
Something other than stool-based/scoping
|
4 Participants
|
8 Participants
|
8 Participants
|
10 Participants
|
6 Participants
|
|
Intentions to Adhere Test Preference Indication
Would not follow recommendation
|
10 Participants
|
12 Participants
|
8 Participants
|
8 Participants
|
14 Participants
|
SECONDARY outcome
Timeframe: 15 minutesThis outcome measure will determine how likely participants are to share the messages about colon cancer screening on social media. Response options: Very unlikely (1), unlikely, neither unlikely nor likely, likely, very likely (5) A higher score indicates a favorable outcome, and a lower score indicates a less favorable outcome.
Outcome measures
| Measure |
Overall Preferred
n=420 Participants
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
n=411 Participants
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
n=413 Participants
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
Median Ranked
n=404 Participants
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Control (no Exposure)
n=382 Participants
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
|---|---|---|---|---|---|
|
Likelihood of Sharing Information Via Social Media
3 Neutral
|
100 Participants
|
99 Participants
|
94 Participants
|
87 Participants
|
87 Participants
|
|
Likelihood of Sharing Information Via Social Media
1 Very Unlikely
|
36 Participants
|
47 Participants
|
47 Participants
|
45 Participants
|
22 Participants
|
|
Likelihood of Sharing Information Via Social Media
2 Unlikely
|
43 Participants
|
49 Participants
|
46 Participants
|
31 Participants
|
21 Participants
|
|
Likelihood of Sharing Information Via Social Media
4 Likely
|
133 Participants
|
109 Participants
|
123 Participants
|
135 Participants
|
146 Participants
|
|
Likelihood of Sharing Information Via Social Media
5 Very Likely
|
108 Participants
|
107 Participants
|
103 Participants
|
106 Participants
|
106 Participants
|
SECONDARY outcome
Timeframe: 15 minutesPopulation: One participant in the Control group did not complete this item.
This outcome will report the count of participants will seek more information after the study. The participants will be asked a question on if they would like more information (Yes/No) and survey vendor will track participants who click a link to an external resource like the American Cancer Society to learn more.
Outcome measures
| Measure |
Overall Preferred
n=420 Participants
Participants in the Overall Preferred arm will be shown four Overall Preferred messages.
Overall Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by all participants in the prior study.
|
Black American Preferred
n=411 Participants
Participants in the Black American Preferred arm will be shown four Black American Preferred messages.
Black American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by Black participants but not White participants in the prior study.
|
White American Preferred
n=413 Participants
Participants in the White American Preferred arm will be shown four White American Preferred messages.
White American Preferred Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were highly rated messages by White participants but not Black participants.
|
Median Ranked
n=404 Participants
Participants in the Median Ranked Arm will be shown four Median Ranked messages.
Median Ranked Cancer Screening Messaging: Strong message content that increases screening and sharing intentions. Messages in this intervention were median ranked in the prior study.
|
Control (no Exposure)
n=381 Participants
Participants in the Control Arm will not be shown any messages.
Control: There will be no message content of cancer screening and sharing intentions in this arm.
|
|---|---|---|---|---|---|
|
Information Sharing Behavior
Yes
|
121 Participants
|
123 Participants
|
127 Participants
|
112 Participants
|
110 Participants
|
|
Information Sharing Behavior
No
|
299 Participants
|
288 Participants
|
286 Participants
|
292 Participants
|
271 Participants
|
Adverse Events
Overall Preferred
Black American Preferred
White American Preferred
Median Ranked
Control (no Exposure)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place